Our People

(AM), (The Florey)

Professor Bernhardt (FAAHMS) is one of Australia’s leading rehabilitation trialists and a leading diversity and gender equity advocate.

(OAM)

Brenda Booth is the survivor of a stroke, which occurred in 2001 at the age of 41. Brenda is a Registered Nurse with extensive experience working in the public and private hospital sectors as well as the Government Disability sector. Brenda has been awarded an Order of Australia in recognition of her services to consumer advocacy in stroke. Ms Booth’s consumer advisory roles commenced in 2004 and include work for the Agency for Clinical Innovation, Stroke Network NSW, Stroke Network Executive Committee (with Professor Lindley); Stroke Foundation Working Party for the National Guidelines (2007 & 2010) and the now Living Clinical Guidelines (2018–); Stroke Foundation Research Advisory Committee (2016 – 2023); Australian Commission on Safety and Quality in Health Care, stroke consumer on Stroke Topic Working Group for the National Clinical Care Standard for Stroke (January 2013 – September 2014), with Professors Lindley and Cadilhac, Bernhardt and Levi; stroke consumer on Australian Stroke Coalition (2018-). In 2021 Brenda was recognised for her achievements by the World Stroke Organisation and World Stroke Academy “Women in Stroke Initiative”.

(OAM) (Bond University)

Professor Hoffmann (FAHMS) is Professor of Clinical Epidemiology and NHMRC Senior Research Fellow at the Institute for Evidence-Based Healthcare, Bond University.

(Edith Cowan University and Sir Charles Gairdner Osbourne Park Health Care Group)

Associate Professor Godecke is a leading academic speech pathologist with expertise in the early management of aphasia and stroke outcomes. Professor Godecke holds the position of Vice Chancellor’s Professorial Fellow at ECU and a conjoint role as Director of Allied Health Research at Sir Charles Gairdner Osbourne Park Health Care Group. She received Edith Cowan University’s Research Mentor of the Year award in 2022 and North Metropolitan Health researcher of the year in 2023. Her previous leadership awards include a Stroke Foundation Future Leaders Award and the Stroke Foundation/Stroke Society of Australasia National Stroke Care Champion award for her commitment to stroke.

MBBS, MD, FRCPEdin, FRACP, FAHA, FESO, FWSO, FAHMS

Graeme Hankey is Perron Institute Chair in Stroke Research at The University of Western Australia and the Perron Institute for Neurological and Translational Science, Perth, Australia. He has led large international clinical trials including the VITATOPS and AFFINITY trials, and is now co-leading the SEANCON phase 2 trial of the cerebroprotectant ARG-007 in acute ischaemic stroke and the Librexia Stroke phase 3 trial of milvexian for secondary stroke prevention. He is the Data Safety Monitoring Board chair of 3, and member of 6, ongoing clinical trials. He is an Associate Editor of Circulation, Editorial Consultant for The Lancet Neurology and JACC Advances, Section co-Editor for the Epidemiology, Outcomes, & Population Science section of Stroke, editorial board member of Neuro-epidemiology and a senior editor of Cerebrovascular Diseases. He is a Web of Science Clarivate Analytics Highly Cited Researcher for 2017-2019, having authored or co-authored 13 books and >1070 publications, which have yielded > 162,000 citations (h-index 150). He has delivered > 595 invited lectures at international (n=355), national (n=133), and local (n=107) scientific meetings. He was awarded the 2015 American Stroke Association David G. Sherman Award for outstanding lifetime contributions in the field of stroke. https://research-repository.uwa.edu.au/en/persons/graeme-hankey

The George Institute, University of New South Wales

Professor Hackett is the Head, Student and Fellows Program at The George Institute for Global Health, UNSW and Professor of Epidemiology at The University of Central Lancashire in the United Kingdom. Professor Hackett will contribute to clinical trial activities bringing expertise in: large scale, multicentre, international clinical trials; consumer support and participation in trial design; and mentoring. MH will take a lead role in advising on psychological and psychiatric outcome measurement across included trials and epidemiological research.

(Stroke Foundation)

In the role as National Manager, Stroke TreatmentClinical Services, Kelvin oversees the development and implementation of the Australian and New Zealand living stroke guidelines, the National Stroke Audit, the content and functionality of ‘InformMe’ (the website exclusively supporting the clinical stroke community in Australia), and other national clinical and policy activity for the Stroke Foundation.

(Monash University)

Professor Lannin is a Professor in Neuroscience (Monash University), holds a Chair in Allied Health Research (Alfred Health), has a postgraduate certificate in implementation science (UCSF) and is an occupational therapist by background. Professor Lannin is the Chair of the Management Committee for the Australian Stroke Clinical Registry (AuSCR), Chair of the Data Linkage CI meetings for the AuSCR–Australasian Rehabilitation Outcomes Centre (AROC), member of the Stroke Foundation Clinical Council, occupational therapy representative for the Australian Stroke Coalition, and professional lead for the NHMRC National Guidelines for Stroke. Professor Lannin is also a current Heart Foundation Future Leader and a past NHMRC, MRFF and TRIP fellow awardee.

(University of Adelaide)

Professor Kleinig is the Head of South Australia’s sole Comprehensive Stroke Centre (the Royal Adelaide Hospital), and Chair of the SA Stroke Community of Practice. He is the President of the Australian and New Zealand Stroke Organisation, Co-Chair of the Australian Stroke Coalition, Chair of the Stroke Unit Certification Committee, and National Clinical Lead for the 30/60/90 National Stroke Targets. He also Chairs the national annual telestroke forum.